Home > Annual Financials > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA) Financial Statement Analysis
[BOM: 524500|NSE : KILITCH]

The Revenues of KILITCH DRUGS (INDIA) have increased by 18.74% YoY .
The Earnings Per Share (EPS) of KILITCH DRUGS (INDIA) has decreased by -52.14 % YoY.
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Annual Financial Results
[BOM: 524500|NSE : KILITCH]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹235 Cr₹198 Cr₹154 Cr₹140 Cr₹114 Cr
Expenses ₹198 Cr₹167 Cr₹130 Cr₹122 Cr₹104 Cr
Operating Profit (Excl OI) ₹37 Cr₹32 Cr₹24 Cr₹18 Cr₹11 Cr
Other Income ₹11 Cr₹11 Cr₹4.48 Cr₹2.92 Cr₹2.91 Cr
Interest ₹6.29 Cr₹5.32 Cr₹6.04 Cr₹5.08 Cr₹1.33 Cr
Depreciation ₹3.62 Cr₹3.11 Cr₹3.35 Cr₹3.55 Cr₹2.47 Cr
Profit Before Tax ₹39 Cr₹34 Cr₹19 Cr₹12 Cr₹9.61 Cr
Profit After Tax ₹30 Cr₹25 Cr₹14 Cr₹8.28 Cr₹6.21 Cr
Consolidated Net Profit ₹30 Cr₹27 Cr₹15 Cr₹10 Cr₹7.37 Cr
Earnings Per Share (Rs)₹9.27₹19.37₹9.08₹6.71₹4.73
PAT Margin (%)17.1817.168.795.935.44
ROE(%)11.0714.548.435.864.73
ROCE(%)12.3716.9013.3010.267.26
Total Debt/Equity(x)0.270.190.180.150.15

Key Financials

Market Cap : ₹ 703.5 Cr
Revenue (TTM) : ₹ 237.2 Cr
Net Profit(TTM) : ₹ 29.2 Cr
EPS (TTM) : ₹ 8.3
P/E (TTM) : 24.1

Industry Peers & Returns1W1M1Y
KILITCH DRUGS (INDIA) 0.9% -8.8% 11.7%
SUN PHARMACEUTICAL INDUSTRIES 2% -4.4% 3.7%
DIVIS LABORATORIES 7.1% 2.5% 46.6%
TORRENT PHARMACEUTICALS 1.4% -5.7% 27.6%
CIPLA 2% -0.2% -14.3%
DR REDDYS LABORATORIES 3.6% 8% 4.2%
MANKIND PHARMA 8.1% -2.2% 1.2%
LUPIN 3% -2.5% 3.5%
ZYDUS LIFESCIENCES 7.4% 4.1% 17.9%


KILITCH DRUGS (INDIA) Revenues
[BOM: 524500|NSE : KILITCH]

Y-o-Y

18.74 %

5 Yr CAGR

19.82 %

Years Revenues % Change
Mar2026 ₹235 Cr
18.74
Mar2025 ₹198 Cr
28.47
Mar2024 ₹154 Cr
10.58
Mar2023 ₹140 Cr
22.20
Mar2022 ₹114 Cr -


KILITCH DRUGS (INDIA) Operating Profit
[BOM: 524500|NSE : KILITCH]

Y-o-Y

17.59 %

5 Yr CAGR

37.31 %

Years Operating Profit % Change
Mar2026 ₹37 Cr
17.59
Mar2025 ₹32 Cr
30.84
Mar2024 ₹24 Cr
36.84
Mar2023 ₹18 Cr
68.82
Mar2022 ₹11 Cr -

Operating Margins
Y-o-Y

-1.00 %

5 Yr CAGR

14.60 %

Years Operating Margin% % Change
Mar2026 15.85%
-1.00
Mar2025 16.01%
1.84
Mar2024 15.72%
23.78
Mar2023 12.7%
38.19
Mar2022 9.19% -

KILITCH DRUGS (INDIA) Profit After Tax
[BOM: 524500|NSE : KILITCH]

Y-o-Y

12.98 %

5 Yr CAGR

42.25 %

Years Profit After Tax % Change
Mar2026 ₹30 Cr
12.98
Mar2025 ₹27 Cr
82.87
Mar2024 ₹15 Cr
39.75
Mar2023 ₹10 Cr
41.82
Mar2022 ₹7.37 Cr -

PAT Margins
Y-o-Y

0.12 %

5 Yr CAGR

33.31 %

Years PAT Margin(%) % Change
Mar2026 17.18 %
0.12
Mar2025 17.16 %
95.22
Mar2024 8.79 %
48.23
Mar2023 5.93 %
9.01
Mar2022 5.44 % -

KILITCH DRUGS (INDIA) Earnings Per Share (EPS)
[BOM: 524500|NSE : KILITCH]

Y-o-Y

-52.14 %

5 Yr CAGR

18.32 %

Years EPS % Change
Mar2026 ₹9.27
-52.14
Mar2025 ₹19
113.33
Mar2024 ₹9.08
35.32
Mar2023 ₹6.71
41.86
Mar2022 ₹4.73 -

KILITCH DRUGS (INDIA) Return on Capital Employed (ROCE)
[BOM: 524500|NSE : KILITCH]

Y-o-Y

-26.80 %

5 Yr CAGR

14.25 %

Years ROCE % Change
Mar2026 12.37%
-26.80
Mar2025 16.9%
27.07
Mar2024 13.3%
29.63
Mar2023 10.26%
41.32
Mar2022 7.26% -

KILITCH DRUGS (INDIA) Share Price vs Sensex

Current Share Price : ₹201.0
Current MarketCap: ₹ 703.5 Cr
Updated EOD on :Oct 30,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

0.9%

-8.8%

11.7%

SENSEX

1.8%

2.3%

-11.9%

KILITCH DRUGS (INDIA) related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 6.9% -1.9% 10.9%
No NSE index found

You may also like the below Video Courses


FAQ about KILITCH DRUGS (INDIA) Financials


How the annual revenues of KILITCH DRUGS (INDIA) have changed ?

The Revenues of KILITCH DRUGS (INDIA) have increased by 18.74% YoY .

How the Earnings per Share (EPS) of KILITCH DRUGS (INDIA) have changed?

The Earnings Per Share (EPS) of KILITCH DRUGS (INDIA) has decreased by -52.14 % YoY .